PUMA and NOXA Expression in Tumor-Associated Benign Prostatic Epithelial Cells Are Predictive of Prostate Cancer Biochemical Recurrence

SIMPLE SUMMARY: After receiving a diagnosis of prostate cancer, patients follow a routine treatment plan based on tumor grade, stage and prostate-specific antigen (PSA) level. However, studies in other cancers have shown the importance of using biomarkers to personalize treatments. With no approved...

Descripción completa

Detalles Bibliográficos
Autores principales: Clairefond, Sylvie, Péant, Benjamin, Ouellet, Véronique, Barrès, Véronique, Tian, Zhe, Trudel, Dominique, Karakiewicz, Pierre I., Mes-Masson, Anne-Marie, Saad, Fred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692508/
https://www.ncbi.nlm.nih.gov/pubmed/33138186
http://dx.doi.org/10.3390/cancers12113187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692508/
https://www.ncbi.nlm.nih.gov/pubmed/33138186
http://dx.doi.org/10.3390/cancers12113187

Ejemplares similares